SLC4A3相关短QT综合征的人诱导多能干细胞心肌细胞模型:室性心律失常与心源性猝死机制
本研究利用两例家族性短QT综合征(SQTS)患者来源的hiPSC-CMs及CRISPR/Cas9校正的等基因细胞系,结合HEK 293T细胞过表达和人器官模型光学标测,发现SLC4A3变异(p.Arg370Cys和p.Lys531Thr)导致功能丧失、细胞内碱化、L型钙电流(ICa-L)降低和APD缩短,并通过增强钠钙交换电流(INCX)诱发延迟后除极(DAD),奎尼丁和索他洛尔可延长APD并减少心律失常样事件。
要点
- SLC4A3变异通过功能丧失导致细胞内碱化,进而降低ICa-L并缩短APD。
- 增强的INCX诱发DAD是SLC4A3相关SQTS心律失常的机制。
- 奎尼丁和索他洛尔可延长APD并减少SQTS-hiPSC-CMs的心律失常样事件。
核心结论
- SLC4A3相关SQTS变异导致功能丧失,引起细胞内碱化、ICa-L降低和APD缩短,从而解释短QT临床表型。
- 心律失常事件由增强的INCX诱发DAD所触发。
研究设计与样本
- 研究评估了两个新型SLC4A3变异(p.Arg370Cys和p.Lys531Thr)在各自家族中导致SQTS的功能和病理生理。
- 构建了每例先证者来源的hiPSC-CMs、CRISPR/Cas9 variant correction的等基因细胞系,以及转染WT或变异SLC4A3表达构建体的HEK 293T细胞。
- 采用膜片钳、Ca2+成像、单细胞收缩、细胞内pH测量、蛋白结构分析、免疫染色和人器官模型光学标测进行生理学表征。
主要发现
- SQTS-hiPSC-CMs显示APD显著缩短,且自发动作电位、钙瞬变成像和单细胞收缩节律记录到更高的心律失常样事件发生率。
- SQTS-hiPSC-CMs的L型钙通道电流(ICa-L)降低,钠钙交换电流(INCX)显著增加。
- 突变细胞记录到频繁的DAD事件,而WT或等基因细胞系未记录到。
- SQTS-hiPSC-CMs和表达突变SLC4A3的转染异源细胞中细胞内pH值较WT-SLC4A3显著升高(碱性)。
- NH4Cl诱导WT-hiPSC-CMs碱化可导致APD缩短、INCX增强和ICa-L降低,与表达突变SLC4A3蛋白的细胞观察相似。
临床怎么用
- 对于SLC4A3相关SQTS,奎尼丁和索他洛尔在细胞模型中可延长APD并减少DAD,提示潜在药物治疗方向。
- 机制上针对细胞内碱化、INCX增强或ICa-L降低可能成为未来干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Short QT syndrome (SQTS) is an inherited channelopathy that can cause sudden cardiac death. Recent research has implicated mutations in the SLC4A3 gene as a cause of SQTS, but the mechanisms of shortened action potential duration (APD) and arrhythmia vulnerability have not been described. This study aims to evaluate the underlying pathophysiology causing a shortened APD and ventricular arrhythmia vulnerability in SLC4A3-associated SQTS through mechanistic studies of novel SLC4A3 mutations responsible for familial SQTS. METHODS: This study evaluated the function and pathophysiology of two novel SLC4A3 variants (p.Arg370Cys and p.Lys531Thr) responsible for SQTS in their respective families. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) from each index SQTS patient were developed, as well as an isogenic cell line with variant correction (using CRISPR/Cas9) and HEK 293T cells transfected with SLC4A3 expression constructs expressing either wild type (WT) SLC4A3 or the variants. SLC4A3-SQTS variants were physiologically characterized by patch-clamp analysis, Ca2+ imaging, single cell contraction, intracellular pH measurement, protein structure analyses, immunostaining, and optical mapping studies in a human organoid model. RESULTS: SQTS-hiPSC-CMs showed significantly shorter APD and a higher rate of arrhythmia-like events, as recorded by spontaneous action potentials, calcium transient imaging, and rhythmicity of visualized single cell contractions. SQTS-hiPSC-CMs exhibited decreased L-type calcium channel current (ICa-L), and significantly increased Na/Ca exchange current (INCX). Frequent delayed afterdepolarization (DAD) events were recorded from mutant cells but not WT or isogenic cell lines. The intracellular pH value was significantly higher (alkaline) in SQTS-hiPSC-CMs and in transfected heterologous cells expressing mutant SLC4A3, as compared to WT-SLC4A3. Experimental-induced alkalinization of WT-hiPSC-CMs by NH4Cl resulted in shortened APD, enhanced INCX, and reduced ICa-L, similar to observations in cells expressing mutant SLC4A3 proteins. Quinidine and sotalol were found to prolong APD and decrease the occurrence of arrhythmia-like events (DADs) in SQTS-hiPSC-CMs. CONCLUSIONS: In human cell models, SLC4A3 mutations responsible for SQTS result in loss-of-function leading to intracellular alkalinization, decreased ICa-L, and shortened APD, accounting for the clinical phenotype of short QT. Arrhythmic events in SLC4A3-associated SQTS are provoked by enhanced INCX evoking DADs.
引用
- Meng Z, Kovacs B, Yan C, et al. SLC4A3-related short QT syndrome assessed in human induced pluripotent stem cell-derived cardiomyocytes: mechanisms of ventricular arrhythmia and sudden cardiac death. Eur Heart J. 2026. PMID: 41780556. doi:10.1093/eurheartj/ehag068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。